SUMMARY: Over 600 frozen waffle products from various brands are being recalled due to potential listeria contamination, detected through routine testing at a manufacturing facility. Fortunately, there have been no confirmed cases of illness or death associated with these products. They are sold at major retailers like Target and Walmart, which have responded by removing the affected items from stores and placing sales restrictions on them. The increase in listeria recalls is attributed to a more complex food supply chain, higher consumer demand for ready-to-eat processed foods, and advances in testing that allow for better detection of foodborne pathogens.

More than 600 frozen waffle products are being voluntarily recalled due to a potential listeria contamination.

KFF Health News’ Celiné Gounder joined CBS Mornings to discuss what to do if you have one of the affected products.
#waffles #listeria

Source

SUMMARY: Pam McClure, una beneficiaria de Medicare de 70 años, anticipa ahorrar casi $4,000 en medicamentos gracias a la Ley de Reducción de la Inflación (IRA) de 2022, que limita los gastos de bolsillo a $2,000 en 2025. La ley también reduce copagos de insulina y permite que Medicare negocie precios. Sin embargo, algunos planes incrementarán sus primas significativamente. El período de inscripción anual comenzó el 15 de octubre y finalizará el 7 de diciembre; los beneficiarios deben comparar planes para evitar sorpresas y costos más altos. La IRA introduce cambios significativos en la cobertura de medicamentos de Medicare.

Read the full article

The post Beneficiarios de Medicare gastarán menos en medicamentos en 2025 appeared first on kffhealthnews.org

SUMMARY: Pam McClure is set to save nearly $4,000 on her prescription drugs next year due to new Medicare regulations under the Biden administration’s Inflation Reduction Act (IRA). Starting in 2025, out-of-pocket costs for Medicare enrollees will be capped at $2,000, significantly helping many, including the 3.2 million affected seniors. While some Medicare drug plan premiums will decrease, many will see increases, leading to concerns among beneficiaries. The IRA also introduces a $35 copayment limit for insulin and enables price negotiations with pharmaceutical companies. As enrollment begins, beneficiaries are advised to evaluate their options carefully to avoid missing potential savings.

Read the full article

The post Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More. appeared first on kffhealthnews.org